ĚěĂŔ´«Ă˝

Filters close
Newswise: Wild-Fire-Banner.jpg
Released: 13-Dec-2024 5:20 PM EST
Exposure to Remote Wildfire Smoke Drifting Across the U.S. Linked to Increased Medical Visits for Heart and Lung Problems
University of Maryland School of Medicine

New Study Found Increased Medical Visits for Heart and Respiratory Problems in Baltimore on Poor Air Quality Days from Western Canadian Wildfires

Released: 5-Dec-2024 12:00 AM EST
Researchers Discover New Neurons that Suppress Food Intake
University of Maryland School of Medicine

In a study published in the Dec. 5 issue of Nature, a team of researchers discovered a new population of neurons that is responsive to the hormone leptin. Leptin responsive neurons are important in obesity since leptin is sent to the brain from the body’s fat stores to suppress hunger.

Newswise: Greenebaum-Cancer-Center-Signage-NEW-3.jpg
Released: 4-Dec-2024 11:45 AM EST
Business Leader and Philanthropist Michael Greenebaum Named New Chair of the University of Maryland School of Medicine's Board of Visitors
University of Maryland School of Medicine

University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, has announced that prominent business leader and philanthropist Michael Greenebaum has been named Chair of the School's Board of Visitors. Mr. Greenebaum served as the Inaugural Vice Chair of the Board of Visitors since 2021 and has been a board member since 2012.

Newswise: Snoring-banner.jpg
Released: 21-Nov-2024 3:50 PM EST
UM School of Medicine Researchers Link Snoring to Behavioral Problems in Adolescents without Declines in Cognition
University of Maryland School of Medicine

Adolescents who snore frequently were more likely to exhibit behavior problems such as inattention, rule-breaking, and aggression, but they do not have any decline in their cognitive abilities, according to a new study conducted by researchers at the University of Maryland School of Medicine (UMSOM).

Newswise: Marijuana-Womb-Banner.jpg
Released: 13-Nov-2024 5:00 PM EST
Exposure to Marijuana in the Womb May Increase Risk of Addiction to Opioids Later in Life, Study Finds
University of Maryland School of Medicine

University of Maryland School of Medicine Researchers Identify Neurobiological Changes Leading to Increase Release of the Brain Chemical Dopamine and Its Target Neurons Linked to Addiction-Like Behavior With the increased legalization of recreational cannabis, as many as 1 in 5 pregnant women in the U.S. are now using the drug to help with morning sickness, lower back pain or anxiety.

30-Oct-2024 3:25 PM EDT
Genomic Databases Need More Diversity
University of Maryland School of Medicine

Researchers at the Institute for Genome Sciences (IGS) at the University of Maryland School of Medicine (UMSOM) have developed a broad and deep genomic database of Latin Americans which gathers genome-wide data of Latin American populations into a single source and allows other scientists to easily add that population to their own research studies without straining budgets.

Newswise: UM School of Medicine's Margaret M. McCarthy, PhD, Elected as Member of Prestigious National Academy of Medicine
Released: 23-Oct-2024 1:00 PM EDT
UM School of Medicine's Margaret M. McCarthy, PhD, Elected as Member of Prestigious National Academy of Medicine
University of Maryland School of Medicine

Margaret M. McCarthy, PhD, an internationally-recognized neuroscientist, who is the James and Carolyn Frenkil Dean’s Endowed Professor in the University of Maryland School of Medicine's Department of Pharmacology, Physiology, and Drug Development, and Director of the University of Maryland – Medicine Institute of Neuroscience Discovery (UM-MIND), has been elected as a new member of the National Academy of Medicine.

Newswise: Eastern-Shore-campus.jpg
Released: 9-Oct-2024 12:05 PM EDT
UMSOM Launches New Rural Health Initiative to Address Physician Shortage on Maryland's Eastern Shore
University of Maryland School of Medicine

With a commitment to addressing rural health disparities and the challenges faced by Maryland’s rural Eastern Shore residents, the University of Maryland School of Medicine has launched the Rural Health Equity and Access Longitudinal Elective (R-HEALE).

Newswise: UM School of Medicine Establishes Three New Endowed Professorships through Maryland E-Nnovation Awards and UMB Matching Funds
Released: 18-Sep-2024 12:05 PM EDT
UM School of Medicine Establishes Three New Endowed Professorships through Maryland E-Nnovation Awards and UMB Matching Funds
University of Maryland School of Medicine

University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, announced today that the School of Medicine has been awarded $2 million in matching funds from the Maryland E-Nnovation Initiative Fund (MEIF), administered by the Maryland Department of Commerce. The funds, totaling $4 million when combined with UMB qualified funding, will enable the establishment of three endowed research professorships.

Newswise: Martin-Lab3-Banner.jpg
Released: 17-Sep-2024 2:05 PM EDT
UM School of Medicine Aims to Accelerate Basic Science Research and Advance Drug Therapies with Newly-Created Department
University of Maryland School of Medicine

University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, has announced the formation of a new Department of Pharmacology, Physiology and Drug Development, which merges the Department of Physiology and Department of Pharmacology. This new Department aligns the basic science research efforts of both entities with a strong emphasis on the development of new drug therapies.

Released: 28-Aug-2024 12:05 PM EDT
Leading Computational Scientist and Oncology Researcher Elana Fertig, PhD, Appointed as New Director of the Institute for Genome Sciences at the University of Maryland School of Medicine
University of Maryland School of Medicine

University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today the appointment of Elana J. Fertig, PhD, FAIMBE, as the new Director of the School’s Institute for Genome Sciences (IGS).

Newswise: Nationally Recognized Behavioral Scientist Dr. Kelly Dunn Named Director of the Kahlert Institute for Addiction Medicine at the University of Maryland School of Medicine
Released: 19-Aug-2024 1:05 PM EDT
Nationally Recognized Behavioral Scientist Dr. Kelly Dunn Named Director of the Kahlert Institute for Addiction Medicine at the University of Maryland School of Medicine
University of Maryland School of Medicine

University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today the appointment of Kelly Dunn, PhD, MBA, one of the nation’s leading researchers on opioid use disorder, as the inaugural Director of the School’s Kahlert Institute for Addiction Medicine

Newswise: Study: Living in Disadvantaged Neighborhoods Influences Stress-Related Genes, Which May Contribute to Aggressive Prostate Cancer in African American Men
Released: 15-Aug-2024 4:05 PM EDT
Study: Living in Disadvantaged Neighborhoods Influences Stress-Related Genes, Which May Contribute to Aggressive Prostate Cancer in African American Men
University of Maryland School of Medicine

Study: Living in Disadvantaged Neighborhoods Influences Stress-Related Genes, Which May Contribute to Aggressive Prostate Cancer in African American Men

Newswise: Patients with Unexplainable Chronic Itch Have Unique Blood Biomarkers that Could Eventually Lead to New Targeted Treatments
Released: 14-Aug-2024 2:05 PM EDT
Patients with Unexplainable Chronic Itch Have Unique Blood Biomarkers that Could Eventually Lead to New Targeted Treatments
University of Maryland School of Medicine

Millions of patients worldwide suffer from a chronic itching condition with no identifiable cause – a condition known as chronic pruritus of unknown origin (CPUO) – that has no targeted therapies approved to treat it. Many of these patients suffer for years with little relief, but a new University of Maryland School of Medicine study may provide hope for future treatments. Patients were found to have lower than normal levels of metabolite biomarkers in the blood plasma that could point to a cause of their excruciating symptoms.

Newswise: Orthopaedic Surgeon-Scientist Dr. Frank Henn Named Chair of the Department of Orthopaedics
Released: 29-Jul-2024 1:05 PM EDT
Orthopaedic Surgeon-Scientist Dr. Frank Henn Named Chair of the Department of Orthopaedics
University of Maryland School of Medicine

Dr. Henn is Established Academic Leader with Strong Track Record of Success in Research and Clinical Care; Led Department’s Residency Program to Become Among Top in the Nation

Newswise: Faculty Physicians to Establish New Community
Released: 9-Jul-2024 10:05 PM EDT
Faculty Physicians to Establish New Community "Health Village" at Mondawmin Mall
University of Maryland School of Medicine

New Leased Space Will Include Adult and Pediatric Primary Care, Mental Health Services, Prenatal Care, and Nutrition Counseling

   
Newswise: Itchy-Skin-Banner.jpg
Released: 5-Jun-2024 5:05 PM EDT
Drug Used to Treat Eczema May Provide Relief for Patients with Intensely Itchy Skin Diseases
University of Maryland School of Medicine

Clinical Trial Finds Oral Medication Significantly Reduced Prurigo Nodularis and Chronic Pruritus of Unknown Origin Symptoms A drug approved to treat eczema provided significant improvement in the symptoms of patients with severe itching diseases that currently have no targeted treatments, according to a new study published in JAMA Dermatology.

Newswise: Tennant_Sharon.jpg
Released: 21-May-2024 12:05 PM EDT
University of Maryland School of Medicine Launches Vaccine Development Program to Prevent Sepsis in Newborns
University of Maryland School of Medicine

University of Maryland School of Medicine (UMSOM) researchers at the Center for Vaccine Development and Global Health (CVD) have been awarded $3.96 million to develop a maternal vaccine that prevents sepsis caused by Klebsiella pneumoniae in newborns and infants.

1-May-2024 1:05 PM EDT
Women Need Better Treatments for Bacterial Vaginosis
University of Maryland School of Medicine

Bacterial Vaginosis (BV) affects about one-quarter of reproductive-age women and is linked to adverse health outcomes, such as increased HIV risk. Yet for decades, BV treatment in the United States has largely relied on antibiotics, and BV recurrence is common following antibiotic therapy.



close
0.13139